THE MAIN ACTIVITIES:

Regulation of the process of acquisition of goods, works and services for needs of Scientific Centre of Drug and Medical Technology Expertise after academician E.Gabrielyan.

HEAD OF THE DEPARTMENT:

Marine Petrosyan

Jurist

Phone: (+374 60)83-00-73,  (+374 10)23-08-96, (+374 10)23-16-82+10 07

E-mail:

LEGAL BASIS FOR ACTIVITY:

1. Republic of Armenia Law "On Procurement"

2. Decree of the RA N 386-N of 6 April 2017 «On approving the procedure for carring out E-procurement and repealing decree No 1370-N of 5 december 2013 of the Goverment of the RA»

3. Decree of the RA N 526-N of 4 May 2017 «On approving the procedure for organisation of the procurement process and repealing decree of the Government of the RA No 168-N Of 10 february 2011»

4. Decree of the Government of thy RA N 759-N of 29 June 2017 «On approving the procedure for conferring qualification on procurement co-ordinators and continuous professional training thereof and repealing decree of the Government of the RA No 99-N of 12 february 2015»

Details

Published: 03 November 2017

Hits: 4651

THE MAIN ACTIVITIES:

The main functions are expertise and evaluation of  medical technologies and devices submitted for registration in RA.

HEAD OF THE DEPARTMENT:

Davit Davtyan

chemist

Phone: (+374 60 83-00-73, (+374 10)23-08-96, (+374 10)23-16-82+10 60

E-mail:

LEGAL BASIS FOR ACTIVITY:

Order of the Ministry of Health of Republic of Armenia N3339-A, of November 22, 2017 on using decision N46 of February 12, 2017 of the Eurasian Economic Commission

Order of the Ministry of Health of Republic of Armenia N3398-A, of November 30, 2017 on using decision N29, N42 of February 12, 2016 and N38 of May 12, 2016 of the Council of the Eurasian Economic Commission

Order of the Ministry of Health of Republic of Armenia N3399-A, of November 30, 2017 on using decision N173, N174 of December 22, 2015 and N177 of December 29, 2015 of the Board of the Eurasian Economic Commission

Details

Published: 10 February 2016

Hits: 7422

          The mission of the Centre of Drug and Medical Technology Expertise is to implement the national drug policy, to ensure the safety, efficacy and quality of medicinal products in RA. According to the recommendations of the World Health Organization (WHO), The Scientific Centre of Drug and Medical Technology Expertise (SCDMTE) was founded in 1992 as an organization with managerial, financial and technical independence which is accountable to the Ministry of Health of the RA. 

THE MAIN ACTIVITIES OF THE CENTRE

1. Expertise and evaluation. Expert assessment of medicines (including veterinary drugs), herbal drugs, medical cosmetics, medical devices with the purpose of state registration.

2. Expertise of import and export. Professional expertise of medicines for certification of their import and export.

3. Specialized expertise of pharmaceutical organizations for assuring the appropriate quality of medicines and other pharmaceutical products, available at the pharmaceutical market of Armenia, as well as detecting counterfeit drugs.

4. Control over Narcotics and Psychotropic Substances. Calculation of an annual demand (quota) of narcotics and psychotropic substances in RA, certification of import and export of narcotics and psychotropic substances and submission of reports to UN International Narcotics Control Board.

5. Monitoring adverse effects of drugs. Registration of adverse drug reactions in the RA and provision of relevant information to the WHO International Program on Monitoring Adverse Drug Reactions (Uppsala, Sweden).

6. Implementation of the concept of rational use of drugs. Participation in the Review of the National Essential Medicines List, development of optimal schemes of pharmacotherapy, study of drug prescription practice, carrying out the pharmaco-epidemiological researches.

7. Control of clinical trials. Expertise of protocols and other required documents with the purpose of clinical trials in RA, as well as monitoring of current clinical trials.

8. Informational and publishing activity. Publication of contemporary, objective information on pharmacotherapy, medicines and other pharmaceutical products, as well as guide books, manuals and formularies.

9. Legislative activity. Participation in the development of the legislative documents related to National drug policy and its implementation.

10. Research activity. Conduction of studies in the field of medicine and pharmacy, surveys of pharmaceutical market, pharmaco-economic analysis. The Centre has functioning Scientific Board.

11. Educational activity. Organization of educational workshops and seminars, also in cooperation with WHO and other international organizations.

12. Skill formation and advanced training. Participation in under- and post-graduate educational programs.

The Centre employs more than 80 experts of pharmacology, clinical pharmacology, pharmacy, toxicology, chemistry, and biotechnology. They regularly participate in the international conferences and advanced trainings. 

The Centre has a well-equipped laboratory of drug quality control. 

The Centre has observer status in European Pharmacopoeia Commission since 2009. 

The activity of the Centre has been highly evaluated by WHO and other international organizations.

Details

Published: 06 November 2014

Hits: 114326